Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
Carsten Denkert(Philipps University of Marburg), Roberto Salgado(Institut Jules Bordet), Michael Untch(Helios Kliniken), Sunil Badve(Emory University), Stuart J. Schnitt(Brigham and Women's Hospital), Ewa Chmielik(National Institute of Oncology), Sherene Loi(The University of Melbourne), Anita Bane(University Health Network), Koen Van de Vijver(Cancer Prevention Institute of California), Matthias Christgen(Medizinische Hochschule Hannover), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Peter A. Fasching(Universitätsklinikum Erlangen), David L. Rimm(Yale University), Barbara Ingold Heppner(Charité - Universitätsmedizin Berlin), Hans Kreipe(Medizinische Hochschule Hannover), Sunil R. Lakhani(Sullivan Nicolaides Pathology), Karen Willard‐Gallo(Institut Jules Bordet), Toralf Reimer(University of Rostock), Sandra Demaria(Cornell University), Bruno V. Sinn, Nina Radosevic‐Robin(University of Clermont Auvergne), Audrey Poterie(Institut Gustave Roussy), Frederick Klauschen(Charité - Universitätsmedizin Berlin), Dongxia Gao(Baylor College of Medicine), Frédérique Penault‐Llorca(Inserm), Stefan Michiels(Institut Gustave Roussy), Zuzana Kos(BC Cancer Agency), Giuseppe Floris(KU Leuven), Nicolas Sirtaine(Université Libre de Bruxelles), Stephan Wienert(Charité - Universitätsmedizin Berlin), Giancarlo Pruneri(University of Milan), Jane B. Brock(Brigham and Women's Hospital), S Rim Kim(NSABP Foundation), Sibylle Loibl(Goethe University Frankfurt), Stephen B. Fox(Peter MacCallum Cancer Centre), Giuseppe Viale(University of Milan), Jan Budczies(German Cancer Research Center), Shahinaz Bedri(Weill Cornell Medical College in Qatar), Gert Van den Eynden(GZA Ziekenhuizen Campus Sint-Augustinus), Roland de Wind(Institut Jules Bordet), Gϋnter von Minckwitz(German Breast group), Cécile Colpaert(GZA Ziekenhuizen Campus Sint-Augustinus), Sandra A. O’Toole(Royal Prince Alfred Hospital), Hans‐Peter Sinn(Heidelberg University)
Cited by 281
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k